Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01063816
Recruitment Status : Completed
First Posted : February 5, 2010
Last Update Posted : August 2, 2021
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )